Detalhe da pesquisa
1.
Interim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis - United States, 2022.
MMWR Morb Mortal Wkly Rep
; 71(8): 285-289, 2022 Feb 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35202353
2.
Update of Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat Latent Mycobacterium tuberculosis Infection.
MMWR Morb Mortal Wkly Rep
; 67(25): 723-726, 2018 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-29953429
3.
Latent tuberculosis infection: Misperceptions among non-U.S.-born-populations from countries where tuberculosis is common.
Glob Public Health
; 17(8): 1728-1742, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34228584
4.
CE: Tuberculosis: A New Screening Recommendation and an Expanded Approach to Elimination in the United States.
Am J Nurs
; 117(8): 24-34, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28704234